Outlook Therapeutics, Inc.
(NASDAQ : OTLK)

( )
OTLK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 4.03%69.701.0%$1071.78m
BIIBBiogen, Inc. 0.02%336.711.5%$665.47m
AMGNAmgen, Inc. 0.29%222.791.3%$550.81m
ILMNIllumina, Inc. -1.50%295.943.5%$414.21m
VRTXVertex Pharmaceuticals, Inc. 0.49%246.291.9%$346.37m
REGNRegeneron Pharmaceuticals, Inc. 1.01%403.152.6%$345.56m
ALXNAlexion Pharmaceuticals, Inc. 0.59%103.142.0%$220.13m
AAgilent Technologies, Inc. 0.85%85.061.6%$165.05m
EXASEXACT Sciences Corp. -2.59%99.9824.0%$144.57m
INCYIncyte Corp. -2.27%80.892.5%$113.92m
SGENSeattle Genetics, Inc. -1.12%117.006.1%$113.16m
BMRNBioMarin Pharmaceutical, Inc. 6.13%95.164.3%$102.95m
MRNAModerna, Inc. -1.67%18.230.0%$98.70m
XLRNAcceleron Pharma, Inc. -0.36%94.516.1%$91.83m
ALNYAlnylam Pharmaceuticals, Inc. -1.57%131.038.7%$91.49m

Company Profile

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.